Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials-Reference-Cited by-同舟云学术

Complex vs. non-complex percutaneous coronary intervention with newer-generation drug-eluting stents: an analysis from the randomized BIOFLOW trials

Published:2022-02-25 Issue:7 Volume:111 Page:795-805
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Hemetsberger Rayyan^ORCID,Abdelghani Mohammad,Toelg Ralph,Garcia-Garcia Hector M.,Farhan Serdar,Mankerious Nader,Elbasha Karim,Allali Abdelhakim,Windecker Stephan,Lefèvre Thierry,Saito Shigeru,Kandzari David,Waksman Ron,Richardt Gert

Funder

Biotronik

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00392-022-01994-4.pdf

Reference22 articles.

1. Kereiakes DJ, Sudhir K, Hermiller JB, Gordon PC, Ferguson J, Yaqub M, Sood P, Su X, Yakubov S, Lansky AJ, Stone GW (2010) Comparison of everolimus-eluting and paclitaxel-eluting coronary stents in patients undergoing multilesion and multivessel intervention: the SPIRIT III (A Clinical Evaluation of the Investigational Device XIENCE V Everolimus Eluting Coronary Stent System [EECSS] in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) and SPIRIT IV (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System in the Treatment of Subjects With De Novo Native Coronary Artery Lesions) randomized trials. JACC Cardiovasc Interv 3(12):1229–1239. https://doi.org/10.1016/j.jcin.2010.09.014

2. Byrne RA, Stone GW, Ormiston J, Kastrati A (2017) Coronary balloon angioplasty, stents, and scaffolds. Lancet 390(10096):781–792. https://doi.org/10.1016/S0140-6736(17)31927-X

3. Mohamed MO, Polad J, Hildick-Smith D, Bizeau O, Baisebenov RK, Roffi M, Iniguez-Romo A, Chevalier B, von Birgelen C, Roguin A, Aminian A, Angioi M, Mamas MA (2020) Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry. EuroIntervention 16(7):603–612. https://doi.org/10.4244/EIJ-D-20-00361

4. Genereux P, Giustino G, Redfors B, Palmerini T, Witzenbichler B, Weisz G, Stuckey TD, Maehara A, Mehran R, Kirtane AJ, Stone GW (2018) Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation. Int J Cardiol 268:61–67. https://doi.org/10.1016/j.ijcard.2018.03.103

5. Song PS, Park KT, Kim MJ, Jeon KH, Park JS, Choi RK, Song YB, Choi SH, Choi JH, Lee SH, Gwon HC, Jeong JO, Im ES, Kim SW, Chun WJ, Oh JH, Hahn JY (2019) Safety and efficacy of biodegradable polymer-biolimus-eluting stents (BP-BES) compared with durable polymer-everolimus-eluting stents (DP-EES) in patients undergoing complex percutaneous coronary intervention. Korean Circ J 49(1):69–80. https://doi.org/10.4070/kcj.2018.0097

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between glycemia and multi-vessel lesion in participants undergoing coronary angiography: a cross-sectional study;Frontiers in Cardiovascular Medicine;2024-07-17

2. Drug-Coated Balloon Angioplasty in Patients Undergoing Complex Percutaneous Coronary Intervention;JACC: Asia;2024-07

3. Outcomes After Complex PCI With COMBO Stent Implantation: Insights from a Real-World Pooled Dataset;The American Journal of Cardiology;2023-12

4. 48-Month Clinical Outcomes and Prognostic Factors in an All-Comers Population with Acute Coronary Syndrome and Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention with a Sirolimus-Eluting Stent;Journal of Personalized Medicine;2023-11-03

5. Effect of delayed hospitalization on patients with non-ST-segment elevation myocardial infarction and complex lesions undergoing successful new-generation drug-eluting stents implantation;Scientific Reports;2023-09-26